Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension

Neely Ivgy-May; Goeran Hajak; Gonnie van Osta; Sabine Braat; Qing Chang; Thomas Roth

doi:10.5664/jcsm.8526

Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension

Journal of Clinical Sleep Medicine ◽

10.5664/jcsm.8526 ◽

2020 ◽

Vol 16 (9) ◽

pp. 1455-1467 ◽

Cited By ~ 2

Author(s):

Neely Ivgy-May ◽

Goeran Hajak ◽

Gonnie van Osta ◽

Sabine Braat ◽

Qing Chang ◽

...

Keyword(s):

Primary Insomnia ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension

Annals of Allergy Asthma & Immunology ◽

10.1016/s1081-1206(10)60340-7 ◽

2009 ◽

Vol 102 (4) ◽

pp. 339-347 ◽

Cited By ~ 9

Author(s):

Steven Weinstein ◽

Paul Qaqundah ◽

George Georges ◽

Anjuli Nayak

Keyword(s):

Allergic Rhinitis ◽

Triamcinolone Acetonide ◽

Nasal Spray ◽

Controlled Study ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study

Epilepsy & Seizure ◽

10.3805/eands.11.30 ◽

2019 ◽

Vol 11 (1) ◽

pp. 30-45

Author(s):

Tateki Fujiwara ◽

Rie Teshima ◽

Ikuo Sugiyama ◽

Ken Tsuchida ◽

Yoko Ohtsuka

Keyword(s):

Adjunctive Therapy ◽

Pediatric Patients ◽

Extension Study ◽

Controlled Study ◽

Partial Seizures ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1629757 ◽

2019 ◽

Vol 35 (10) ◽

pp. 1825-1835 ◽

Cited By ~ 3

Author(s):

Lesley M. Arnold ◽

Susan Whitaker ◽

Ching Hsu ◽

David Jacobs ◽

Domenico Merante

Keyword(s):

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Open Label Extension

Download Full-text

Changes in dermatology quality of life, sleep, and symptoms during the 24-week open-label period of XTEND-CIU: A phase IV, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of omalizumab through 48 weeks

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.04.268 ◽

2017 ◽

Vol 76 (6) ◽

pp. AB65

Keyword(s):

Quality Of Life ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iv

Download Full-text

Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension

American Journal of Geriatric Psychiatry ◽

10.1097/jgp.0b013e31815a3e7a ◽

2008 ◽

Vol 16 (1) ◽

pp. 31-43 ◽

Cited By ~ 64

Author(s):

Andreas Tzimos ◽

Viktor Samokhvalov ◽

Michelle Kramer ◽

Lisa Ford ◽

Cristiana Gassmann-Mayer ◽

...

Keyword(s):

Elderly Patients ◽

Extended Release ◽

Controlled Study ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension ◽

Paliperidone Extended Release

Download Full-text

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12235 ◽

2013 ◽

Vol 16 (5) ◽

pp. 418-425 ◽

Cited By ~ 32

Author(s):

T. Kadowaki ◽

K. Kondo

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study

Contraception ◽

10.1016/j.contraception.2005.03.007 ◽

2005 ◽

Vol 72 (3) ◽

pp. 206-211 ◽

Cited By ~ 37

Author(s):

Michelle P. Warren ◽

K.K. Miller ◽

W.H. Olson ◽

S.K. Grinspoon ◽

A.J. Friedman

Keyword(s):

Bone Mineral Density ◽

Oral Contraceptive ◽

Ethinyl Estradiol ◽

Controlled Study ◽

Mineral Density ◽

Open Label ◽

Hypothalamic Amenorrhea ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

Alefacept with methotrexate for treatment of psoriatic arthritis: Open-label extension of a randomized, double-blind, placebo-controlled study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2008.09.050 ◽

2009 ◽

Vol 60 (3) ◽

pp. 402-411 ◽

Cited By ~ 32

Author(s):

Philip J. Mease ◽

Kristian Reich

Keyword(s):

Psoriatic Arthritis ◽

Controlled Study ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension

Download Full-text

A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy

Pain ◽

10.1016/j.pain.2014.05.027 ◽

2014 ◽

Vol 155 (10) ◽

pp. 1943-1954 ◽

Cited By ~ 30

Author(s):

David M. Simpson ◽

Andrew S.C. Rice ◽

Birol Emir ◽

Jaren Landen ◽

David Semel ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Neuropathic Pain ◽

Controlled Trial ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus ◽

Open Label Extension

Download Full-text

Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12236 ◽

2013 ◽

Vol 37 (7) ◽

pp. 691-702 ◽

Cited By ~ 37

Author(s):

C. M. Seiler ◽

J. Izbicki ◽

L. Varga-Szabó ◽

L. Czakó ◽

J. Fiók ◽

...

Keyword(s):

Pancreatic Surgery ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Pancreatic Exocrine Insufficiency ◽

Open Label ◽

Exocrine Insufficiency ◽

Double Blind ◽

Double Blind Placebo ◽

Open Label Extension ◽

Pancreatic Exocrine

Download Full-text